Two Sigma Advisers
VIR icon

Two Sigma Advisers’s Vir Biotechnology VIR Stock Holding History

Two Sigma Advisers’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-577,700
Closed -$3.48M – 2086
2025
Q4 		$3.48M Buy
577,700
+73,700
+15% +$439K 0.01% 970
2025
Q3 		$2.88M Buy
504,000
+189,100
+60% +$967K 0.01% 966
2025
Q2 		$1.59M Buy
314,900
+202,200
+179% +$1.08M ﹤0.01% 1227
2025
Q1 		$730K Buy
112,700
+37,900
+51% +$337K ﹤0.01% 1613
2024
Q4 		$549K Buy
74,800
+32,000
+75% +$252K ﹤0.01% 1741
2024
Q3 		$321K Sell
42,800
-30,700
-42% -$267K ﹤0.01% 1884
2024
Q2 		$654K Buy
+73,500
New +$705K ﹤0.01% 1775
2023
Q4 		– Sell
-15,900
Closed -$149K – 2655
2023
Q3 		$149K Buy
+15,900
New +$227K ﹤0.01% 2151
2023
Q2 		– Sell
-10,900
Closed -$254K – 2674
2023
Q1 		$254K Buy
+10,900
New +$279K ﹤0.01% 2199

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return